Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 748,298 |
|
|||||
| News | - | ||||||
| Day High | 45.92 | Low High |
|||||
| Day Low | 42.30 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Rhythm Pharmaceuticals Inc | RYTM | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -1.60 | -3.61% | 42.77 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 44.66 | 42.30 | 45.92 | 42.77 | 44.37 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 12,861 | 748,298 | US$ 43.58 | US$ 32,609,811 | - | 15.5001 - 52.57 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 17:33:26 | 2 | US$ 43.86 | USD |
Rhythm Pharmaceuticals (RYTM) Options Flow Summary
Rhythm Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 2.57B | 60.14M | - | 77.43M | -184.68M | -3.07 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Rhythm Pharmaceuticals News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RYTM Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 39.15 | 45.92 | 38.90 | 41.79 | 532,948 | 3.62 | 9.25% |
| 1 Month | 39.45 | 45.92 | 35.17 | 38.85 | 508,515 | 3.32 | 8.42% |
| 3 Months | 40.67 | 45.92 | 35.17 | 39.97 | 533,910 | 2.10 | 5.16% |
| 6 Months | 43.87 | 52.57 | 35.17 | 42.69 | 630,302 | -1.10 | -2.51% |
| 1 Year | 17.93 | 52.57 | 15.5001 | 32.97 | 674,212 | 24.84 | 138.54% |
| 3 Years | 19.08 | 52.57 | 3.04 | 20.56 | 766,975 | 23.69 | 124.16% |
| 5 Years | 23.69 | 52.57 | 3.04 | 21.21 | 576,994 | 19.08 | 80.54% |
Rhythm Pharmaceuticals Description
| Rhythm Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the development and commercialization of peptide therapeutics for the treatment of gastrointestinal, or GI, diseases, and genetic deficiencies that result in metabolic disorders. The company's product candidate is setmelanotide (RM 493), which is a potent, melanocortin 4, or MC4, receptor agonist for the treatment of rare genetic disorders of obesity caused by MC4 pathway deficiencies. |
